
Global Gene Editing Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Gene Editing Service market size will reach US$ million by 2031.
Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
United States market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Editing Service players cover Caribou Biosciences, CRISPR Therapeutics, Merck KGaA, Editas Medicine, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gene Editing Service Industry Forecast” looks at past sales and reviews total world Gene Editing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Editing Service sales for 2025 through 2031. With Gene Editing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Editing Service industry.
This Insight Report provides a comprehensive analysis of the global Gene Editing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Editing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Editing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Editing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Editing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Ex-Vivo
In-Vivo
Segmentation by Application:
Commercial
Academic Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Please note: The report will take approximately 2 business days to prepare and deliver.
Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
United States market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Editing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Editing Service players cover Caribou Biosciences, CRISPR Therapeutics, Merck KGaA, Editas Medicine, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gene Editing Service Industry Forecast” looks at past sales and reviews total world Gene Editing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Editing Service sales for 2025 through 2031. With Gene Editing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Editing Service industry.
This Insight Report provides a comprehensive analysis of the global Gene Editing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Editing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Editing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Editing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Editing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Ex-Vivo
In-Vivo
Segmentation by Application:
Commercial
Academic Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
134 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Gene Editing Service Market Size by Player
- 4 Gene Editing Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Gene Editing Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.